RESUMEN
OBJECTIVES: The resection margin (RM) status and microscopic vascular invasion (MVI) are known prognostic factors for intrahepatic cholangiocarcinoma (ICC). An enhanced understanding of their impact on long-term prognosis is required to improve oncological outcomes. METHODS: A total of 711 consecutive patients who underwent curative liver resection for hepatitis B virus-related ICC were retrospectively analyzed. The different impact of the RM status (narrow, <1 cm, or wide, ≥1 cm) and MVI (positive, +, or negative, -) on overall survival (OS) and recurrence-free survival (RFS) were analyzed. RESULTS: The 1-, 3-, and 5-year OS rates were 67.6%, 42.5%, and 33.2% in wide RM & MVI (-), 58.0%, 36.1%, and 26.5% in narrow RM & MVI (-), 51.0%, 27.0%, and 24.3% in wide RM & MVI (+), and 39.0%, 20.4% and 14.3% in narrow RM & MVI (+) (p < 0.001). Multivariate analysis showed that RM & MVI were independent risk factors for the OS and RFS. CONCLUSION: Combined analysis of RM and MVI can better stratify the risks of postoperative death and recurrence in patients with HBV-related ICC, which may help subsequent adjuvant therapy and closer follow-up.
Asunto(s)
Neoplasias de los Conductos Biliares , Colangiocarcinoma , Virus de la Hepatitis B , Neoplasias Vasculares , Adulto , Anciano , Anciano de 80 o más Años , Neoplasias de los Conductos Biliares/mortalidad , Neoplasias de los Conductos Biliares/patología , Neoplasias de los Conductos Biliares/cirugía , Neoplasias de los Conductos Biliares/virología , Colangiocarcinoma/mortalidad , Colangiocarcinoma/patología , Colangiocarcinoma/cirugía , Colangiocarcinoma/virología , Femenino , Hepatectomía/mortalidad , Antígenos de Superficie de la Hepatitis B , Humanos , Metástasis Linfática , Masculino , Márgenes de Escisión , Persona de Mediana Edad , Invasividad Neoplásica , Estudios Retrospectivos , Análisis de Supervivencia , Neoplasias Vasculares/mortalidad , Neoplasias Vasculares/patología , Neoplasias Vasculares/cirugía , Neoplasias Vasculares/virología , Adulto JovenRESUMEN
Epstein-Barr virus-associated smooth muscle tumour (EBV-SMT) is a rare disease occurring in immunosuppressed patients, such as those with AIDS, post-transplantation immunodeficiency and congenital immunodeficiency. Intracranial EBV-SMT after solid organ transplantation has been reported. However, intracranial lesions after bone marrow transplantation are extremely rare. We report the case of a 47-year-old man with a history of acute myeloid leukaemia and bone marrow transplantation. He had symptoms of trigeminal neuralgia, and MRI revealed a left cavernous sinus tumour. He started taking oral gabapentin, but his symptoms did not improve. We performed transnasal endoscopic surgery. Postoperative MRI showed complete removal of the cavernous sinus lesion. Pathological examination showed spindle-shaped cells positive for smooth muscle markers and EBV-encoded small RNA in situ hybridisation. EBV-SMT was pathologically diagnosed. His symptoms improved after surgery. No tumour recurrence was noted on follow-up MRI after 15 months without adjuvant radiation or chemotherapy.
Asunto(s)
Endoscopía/métodos , Infecciones por Virus de Epstein-Barr/diagnóstico , Herpesvirus Humano 4/genética , Huésped Inmunocomprometido , Neoplasias Vasculares/diagnóstico , Biopsia , Seno Cavernoso , Diagnóstico Diferencial , Infecciones por Virus de Epstein-Barr/virología , Humanos , Imagen por Resonancia Magnética , Masculino , Persona de Mediana Edad , ARN Viral/análisis , Ultrasonografía Doppler , Neoplasias Vasculares/cirugía , Neoplasias Vasculares/virologíaRESUMEN
BACKGROUND: Intravascular large B-cell lymphoma (IVLBCL) is an extremely rare subtype of diffuse large B-cell lymphoma that most commonly involves the central nervous system, skin, and bone marrow. To our knowledge, Epstein-Barr virus (EBV)-positive IVLBCL in the liver has never been reported in the literature. CASE PRESENTATION: We report a case of a 65-year-old Chinese man with complaint of fever for 18 days. No obvious abnormality was found by physical examination. Laboratory findings were notable for anemia, thrombocytopenia, and elevated level of serum lactate dehydrogenase. Bone marrow on smear, biopsy, and flow cytometry revealed no lymphoma. Imaging studies showed a slightly lower density lesion in the liver with high fluorodeoxyglucose uptake and hepatosplenomegaly. Percutaneous liver biopsy revealed clustering of large atypical lymphocytes within the hepatic sinusoids. Immunohistochemically, these lymphoma cells were positive for CD20, PAX-5, MUM-1, BCL-6 and CD5, but negative for CD3 and CD10. Besides, Epstein-Barr virus-encoded RNA was detected in tumor cells by in situ hybridization. BCL-2, BCL-6 and MYC genes were intact tested by fluorescence in situ hybridization analysis. The patient was diagnosed as IVLBCL and died after 1 month of hospitalization without receiving immunochemotherapy. CONCLUSIONS: IVLBCL of the liver is a highly rare lymphoma with nonspecific manifestations and dismal prognosis. Full recognition of its clinicopathological features will help to better diagnose this disease.
Asunto(s)
Capilares/patología , Infecciones por Virus de Epstein-Barr/complicaciones , Neoplasias Hepáticas/patología , Linfoma de Células B Grandes Difuso/patología , Neoplasias Vasculares/patología , Anciano , Humanos , Neoplasias Hepáticas/virología , Linfoma de Células B Grandes Difuso/virología , Masculino , Neoplasias Vasculares/virologíaAsunto(s)
Riñón/irrigación sanguínea , Linfoma Extranodal de Células NK-T/patología , Neoplasias Vasculares/patología , Anciano , Antígenos CD/análisis , Infecciones por Virus de Epstein-Barr/complicaciones , Herpesvirus Humano 4/aislamiento & purificación , Humanos , Riñón/patología , Riñón/virología , Linfoma Extranodal de Células NK-T/virología , Masculino , Neoplasias Vasculares/virologíaRESUMEN
Intravascular lymphoma (IVL) is a rare entity. Most cases are a variant of extranodal diffuse large B cell lymphoma, and fewer than 10% of the published cases are of T cell origin. Only intravascular B cell lymphoma is recognized as a distinct entity in the most recent World Health Organization (WHO) classification of lymphoproliferative disorders. We describe a case of cutaneous natural killer (NK)/T IVL, with a cytotoxic immunophenotype and Epstein-Barr virus (EBV) positivity. However, our case was immunohistochemically negative not only for T cell receptor (TCR)-ßF1 and TCR-γ (TCR-silent), but also for CD56, making it the first triple-negative NK/T IVL case to be described. We urge recognition of this NK/T cell lineage intravascular lymphoma due to its particular immunophenotypical profile and its unvarying relationship with EBV. Its occurrence should not be considered a coincidence, but rather a key aspect of the pathogenic background of this haematological neoplasm.
Asunto(s)
Infecciones por Virus de Epstein-Barr/complicaciones , Herpesvirus Humano 4/aislamiento & purificación , Linfoma Cutáneo de Células T/clasificación , Neoplasias Cutáneas/clasificación , Neoplasias Vasculares/clasificación , Anciano de 80 o más Años , Infecciones por Virus de Epstein-Barr/patología , Infecciones por Virus de Epstein-Barr/virología , Humanos , Inmunofenotipificación , Linfoma Cutáneo de Células T/patología , Linfoma Cutáneo de Células T/virología , Masculino , Células T Asesinas Naturales/patología , Células T Asesinas Naturales/virología , Neoplasias Cutáneas/patología , Neoplasias Cutáneas/virología , Neoplasias Vasculares/patología , Neoplasias Vasculares/virologíaRESUMEN
Intravascular selective growth of neoplastic B lymphocytes is a characteristic finding of intravascular large B-cell lymphoma (IVLBCL). However, because neoplastic B cells of IVLBCL grow merely in the lumina of capillaries or small vessels, primary IVLBCL of the great vessels is considered exceptional. To our knowledge, only 2 primary B-cell lymphomas in the lumina of the vena cava have been reported. However, there has been no report of primary B-cell lymphoma with intra-aortic growth. We describe a novel manifestation of primary Epstein-Barr virus-positive large B-cell lymphoma mainly affecting the lumina of the aorta and its major branches in a 76-year-old man. He had a long-term fever that was refractory to antibiotics and aortic mural thrombosis with visceral embolization. Because he had no detectable mass suggesting a malignancy, it was difficult to diagnose while he was alive. He died without anticancer treatment, and the confirmed diagnosis was made at autopsy.
Asunto(s)
Aorta/patología , Linfoma de Células B Grandes Difuso/patología , Neoplasias Vasculares/patología , Anciano , Infecciones por Virus de Epstein-Barr/complicaciones , Herpesvirus Humano 4 , Humanos , Linfoma de Células B Grandes Difuso/virología , Masculino , Trombosis/etiología , Neoplasias Vasculares/virologíaRESUMEN
Classical Kaposi sarcoma (KS) usually appears on lower extremities accompanied or preceded by local lymphedema. However, the development in areas of chronic lymphedema of the arms following mastectomy, mimicking a Stewart-Treves syndrome, has rarely been described. We report an 81-year-old woman who developed multiple, erythematous to purple tumors, located on areas of post mastectomy lymphedema. Histopathological examination evidenced several dermal nodules formed by spindle-shaped cells that delimitated slit-like vascular spaces with some red cell extravasation. Immunohistochemically, the human herpesvirus type 8 (HHV-8) latent nuclear antigen-1 was detected in the nuclei of most tumoral cells confirming the diagnosis of KS. Lymphedema could promote the development of certain tumors by altering immunocompetence. Although angiosarcoma (AS) is the most frequent neoplasia arising in the setting of chronic lymphedema, other tumors such as benign lymphangiomatous papules (BLAP) or KS can also develop in lymphedematous limbs. It is important to establish the difference between AS and KS because their prognosis and treatment are very different. Identification by immunohistochemistry of HHV-8 is useful for the distinction between KS and AS or BLAP.
Asunto(s)
Herpesvirus Humano 8/aislamiento & purificación , Linfedema/patología , Mastectomía/efectos adversos , Sarcoma de Kaposi/patología , Neoplasias Vasculares/patología , Anciano de 80 o más Años , Diagnóstico Diferencial , Femenino , Hemangiosarcoma/diagnóstico , Hemangiosarcoma/patología , Hemangiosarcoma/virología , Herpesvirus Humano 8/inmunología , Humanos , Linfangiosarcoma/diagnóstico , Linfangiosarcoma/patología , Linfedema/virología , Sarcoma de Kaposi/virología , Neoplasias Cutáneas/patología , Neoplasias Cutáneas/virología , Neoplasias Vasculares/virologíaRESUMEN
BACKGROUND: Intravascular NK-cell lymphoma (IVNKL) is an extremely rare variant of non-Hodgkin lymphoma. To our knowledge, there are only a few cases reported in the English literature. Here, a case of a 29-year-old male with IVNKL involving the skin of the trunk and 4 extremities and liver is presented. A comprehensive literature review is undertaken to summarize the clinical and pathological features of this disorder. FINDINGS: In our case, large neoplastic lymphoid cells are restricted to the lumen of small vessels and exhibit the phenotype of a true NK cell. The morphology and immunophenotype, positivity of EBER and NK-cell origin are similar to other IVNKL cases. In addition, some cases including ours carry a poor prognosis as multiple systems or vital organs are involved. CONCLUSION: In summary, we report a case of an unusual intravascular lymphoma of NK-cell lineage that displays both clinical and pathological features and compare it with other differential diagnoses. It is important to recognize this rare entity to make an appropriate diagnosis and achieve a better understanding regarding the treatment and prognosis.
Asunto(s)
Linfoma Extranodal de Células NK-T/patología , Células T Asesinas Naturales/patología , Neoplasias Vasculares/patología , Adulto , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Biomarcadores de Tumor/análisis , Biomarcadores de Tumor/genética , Biopsia , Linaje de la Célula , Diagnóstico Diferencial , Resultado Fatal , Genes Codificadores de los Receptores de Linfocitos T , Herpesvirus Humano 4/genética , Humanos , Inmunohistoquímica , Linfoma Extranodal de Células NK-T/tratamiento farmacológico , Linfoma Extranodal de Células NK-T/genética , Linfoma Extranodal de Células NK-T/inmunología , Linfoma Extranodal de Células NK-T/virología , Masculino , Células T Asesinas Naturales/inmunología , Células T Asesinas Naturales/virología , Fenotipo , Valor Predictivo de las Pruebas , ARN Viral/genética , Tomografía Computarizada por Rayos X , Resultado del Tratamiento , Neoplasias Vasculares/tratamiento farmacológico , Neoplasias Vasculares/genética , Neoplasias Vasculares/inmunología , Neoplasias Vasculares/virologíaRESUMEN
Intravascular large cell lymphoma is a rare subtype of extranodal large cell lymphoma characterized by the presence of neoplastic cells within the lumina of small vessels. Most cases of intravascular large cell lymphoma have a B-cell phenotype. To date, 12 cases of intravascular natural killer (NK/)/T-cell lymphoma (IVNKL) have been reported. Our case is A 47-year-old female presented with erythematous patches and plaques on the lower extremities mimicking panniculitis clinically. A skin biopsy revealed intravascular lymphoma (IVL) with a NK/T cell phenotype (positive for CD3, and granzyme B and negative for CD20, CD4, CD8, CD5). The lymphoma cells were also positive for Epstein-Barr virus by Epstein-Barr virus-encoded RNA in situ hybridization test. Because this type of lymphoma is extremely rare, our case is documented and compared with the previously reported cases.
Asunto(s)
Linfoma Extranodal de Células NK-T/patología , Linfoma Cutáneo de Células T/patología , Paniculitis/patología , Neoplasias Cutáneas/patología , Neoplasias Vasculares/patología , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Biomarcadores de Tumor/análisis , Biopsia , Diagnóstico Diferencial , Femenino , Herpesvirus Humano 4/genética , Humanos , Inmunohistoquímica , Linfoma Extranodal de Células NK-T/química , Linfoma Extranodal de Células NK-T/tratamiento farmacológico , Linfoma Extranodal de Células NK-T/virología , Linfoma Cutáneo de Células T/química , Linfoma Cutáneo de Células T/tratamiento farmacológico , Linfoma Cutáneo de Células T/virología , Persona de Mediana Edad , Valor Predictivo de las Pruebas , ARN Viral/genética , Neoplasias Cutáneas/química , Neoplasias Cutáneas/tratamiento farmacológico , Neoplasias Cutáneas/virología , Resultado del Tratamiento , Neoplasias Vasculares/química , Neoplasias Vasculares/tratamiento farmacológico , Neoplasias Vasculares/virologíaRESUMEN
Intravascular lymphomas are rare and aggressive hematolymphoid tumors. Here, we describe a human herpesvirus type-8 (HHV-8)/Kaposi sarcoma-associated herpesvirus-positive and Epstein-Barr virus (EBV)-positive intravascular lymphoma. The patient was a 59-year-old human immunodeficiency virus-positive man who presented with diarrhea, abdominal pain, fevers, night sweats, and weight loss. Radiographic studies of the abdomen and pelvis revealed numerous subcentimeter nodules within the subcutaneous fat that lacked connection to the skin. An excisional biopsy demonstrated large atypical cells within vessels in the deep subcutaneous fat, and many of the vessels contained extensive organizing thrombi. The atypical cells lacked strong expression of most B-cell markers but were positive for MUM-1 and showed partial expression of several T-cell markers. An immunohistochemical stain for HHV-8 and an in situ hybridization for EBV were both positive in the neoplastic cells. The disease had a rapidly progressive and fatal course. This lymphoma appears to represent an entirely intravascular form of primary effusion lymphoma and highlights the propensity for HHV-8 and EBV-positive lymphoid neoplasms to show aberrant expression of T-cell markers, illustrates the utility of skin biopsies for the diagnosis of intravascular lymphoma, and suggests that biopsies to evaluate for intravascular lymphoma should be relatively deep and include subcutaneous fat.
Asunto(s)
Coinfección , Infecciones por Virus de Epstein-Barr/virología , Infecciones por Herpesviridae/virología , Herpesvirus Humano 4/aislamiento & purificación , Herpesvirus Humano 8/aislamiento & purificación , Linfoma de Efusión Primaria/virología , Neoplasias Vasculares/virología , Biomarcadores de Tumor/análisis , Biopsia , ADN Viral/aislamiento & purificación , Progresión de la Enfermedad , Infecciones por Virus de Epstein-Barr/metabolismo , Infecciones por Virus de Epstein-Barr/patología , Resultado Fatal , Infecciones por Herpesviridae/metabolismo , Infecciones por Herpesviridae/patología , Herpesvirus Humano 4/genética , Humanos , Inmunohistoquímica , Hibridación in Situ , Linfoma de Efusión Primaria/química , Linfoma de Efusión Primaria/patología , Masculino , Persona de Mediana Edad , Pronóstico , Factores de Tiempo , Tomografía Computarizada por Rayos X , Neoplasias Vasculares/química , Neoplasias Vasculares/patologíaAsunto(s)
Linfoma Extranodal de Células NK-T/diagnóstico , Linfoma Cutáneo de Células T/diagnóstico , Neoplasias Cutáneas/diagnóstico , Neoplasias Vasculares/diagnóstico , Adulto , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Biopsia , ADN Viral/análisis , Femenino , Herpesvirus Humano 4/genética , Humanos , Inmunofenotipificación , Hibridación in Situ , Linfoma Extranodal de Células NK-T/tratamiento farmacológico , Linfoma Extranodal de Células NK-T/patología , Linfoma Extranodal de Células NK-T/virología , Linfoma Cutáneo de Células T/tratamiento farmacológico , Linfoma Cutáneo de Células T/patología , Linfoma Cutáneo de Células T/virología , Piel/patología , Piel/virología , Neoplasias Cutáneas/tratamiento farmacológico , Neoplasias Cutáneas/patología , Neoplasias Cutáneas/virología , Resultado del Tratamiento , Neoplasias Vasculares/tratamiento farmacológico , Neoplasias Vasculares/patología , Neoplasias Vasculares/virologíaRESUMEN
OBJECTIVE: To study the clinicopathologic features and disease outcome of intravascular natural killer-cell lymphoma (IVNKL). METHODS: The histologic features, immunohistochemical findings and results of in-situ hybridization for Epstein-Barr virus-encoded RNA (EBER) were analyzed in 2 novel cases of IVNKL. Seven cases of IVNKL previously reported in the literature were reviewed. RESULTS: The patients were a 68-year-old woman and a 22-year-old man. They both presented with erythematous patches and nodules on their trunk and extremities. Skin biopsies confirmed the diagnosis of IVNKL. The tumor cells were positive for CD3, CD56, granzyme B and EBER. Both patients died 2 months after the diagnosis. Amongst the 9 reported cases, including those from the literature, the male was 4 cases, the female was 5 cases. The mean age of the patients was 45.7 years and the median age was 47 years. Skin lesions represented the commonest clinical manifestations. Multiple organ involvement was found in 7 cases and central nervous system was involved in 3 cases. Six patients died during 2 to 17 months of follow-up. The median survival was 9 months and the one-year survival rate was (35.6±18.6)%. The clinical outcome of the patients with multiple organ involvement was worse than that with skin manifestations only. The difference however was not statistically significant (P=0.083). CONCLUSIONS: IVNKL is a rare disease. Diagnosis should be made according to typical histologic findings, immunophenotype and EBER in-situ hybridization results. The overall prognosis of IVNKL is poor. Early diagnosis and treatment before multiorgan involvement may be helpful in improving the clinical outcome.
Asunto(s)
Células Asesinas Naturales/patología , Linfoma no Hodgkin/patología , Neoplasias Vasculares/patología , Anciano , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Complejo CD3/metabolismo , Antígeno CD56/metabolismo , Ciclofosfamida/uso terapéutico , Doxorrubicina/uso terapéutico , Femenino , Estudios de Seguimiento , Granzimas/metabolismo , Humanos , Células Asesinas Naturales/metabolismo , Células Asesinas Naturales/virología , Linfoma no Hodgkin/tratamiento farmacológico , Linfoma no Hodgkin/metabolismo , Linfoma no Hodgkin/virología , Masculino , Persona de Mediana Edad , Prednisona/uso terapéutico , ARN Viral/metabolismo , Neoplasias Vasculares/tratamiento farmacológico , Neoplasias Vasculares/metabolismo , Neoplasias Vasculares/virología , Vincristina/uso terapéutico , Adulto JovenRESUMEN
The majority of cases of intravascular lymphomatosis (IVL) is derived from B cells. However, IVL may also arise from T cells, or more rarely NK cells. The clinicopathological findings in six cases of NK-cell IVL (NK-IVL), including one new case, were summarised and compared with B-cell IVL (B-IVL) and T-cell IVL (T-IVL). Earlier onset of disease and female predominance were found in NK-IVL. NK-IVL was typically Epstein-Barr virus (EBV)-positive, whereas EBV was rarely detected in B-IVL. Cutaneous manifestations were common in NK-IVL with constant EBV infection. B-IVL showed a more favourable prognosis than T- or NK-IVL. Irrespective of immunophenotype, however, IVL showed a less favourable prognosis than ordinary lymphomas within the same immunophenotype. In summary, IVL of the B-, T- and NK-cell phenotypes is clinicopathologically distinct and shows similarities to their more common counterparts, i.e. diffuse large B-cell lymphoma, peripheral T-cell lymphoma, unspecified and extranodal NK/T-cell lymphoma, nasal type.
Asunto(s)
Células Asesinas Naturales/patología , Linfoma no Hodgkin/patología , Neoplasias Vasculares/patología , Adulto , Anciano , Antineoplásicos/uso terapéutico , Femenino , Humanos , Linfoma de Células B , Linfoma no Hodgkin/tratamiento farmacológico , Linfoma no Hodgkin/virología , Linfoma de Células T , Masculino , Persona de Mediana Edad , Resultado del Tratamiento , Neoplasias Vasculares/tratamiento farmacológico , Neoplasias Vasculares/virologíaRESUMEN
Most cases of intravascular large cell lymphoma have a B-cell phenotype, but rare T-cell and natural killer (NK)-cell variants have been reported. We describe the clinicopathologic features of 4 patients (M:F=3:1; age range: 63 to 87; median age: 65) with intravascular large NK/T-cell lymphoma. The skin was the site of presentation in all patients (leg: 1 case; trunk: 1 case; trunk and extremities: 2 cases). Two patients had lesions confined to the skin; in 1 case concomitant involvement of the brain was detected and in 1 case no further studies were carried out. Immunohistology showed positivity for cytotoxic markers in 3/4 cases. One case had an NK phenotype similar to NK/T-cell lymphoma, nasal-type, whereas the other cases could not be precisely classified into specific categories (peripheral T-cell lymphoma, NOS). One of these cases was negative for cytotoxic markers and was positive only for CD2 and CD3 epsilon. Association with Epstein-Barr virus (EBV) was demonstrated in 2 cases by in situ hybridization, whereas 1 case was negative. All our patients had aggressive disease and died between 2 weeks and 7 months from presentation. Analysis of our cases and of those published in the literature shows that intravascular large NK/T-cell lymphoma is a rare, aggressive lymphoma with variable phenotypic features, frequent expression of cytotoxic proteins, true NK-cell phenotype and association with Epstein-Barr virus infection, and common presentation in the skin. Homogeneous studies on larger number of patients and reevaluation of cases published with incomplete phenotypic data would be necessary to gather more information on this extremely rare type of lymphoma.
Asunto(s)
Infecciones por Virus de Epstein-Barr/virología , Linfoma Extranodal de Células NK-T/patología , Linfoma de Células T/patología , Neoplasias Vasculares/patología , Anciano , Anciano de 80 o más Años , Femenino , Humanos , Linfoma Extranodal de Células NK-T/virología , Linfoma de Células T/virología , Masculino , Persona de Mediana Edad , Fenotipo , Neoplasias Vasculares/virologíaAsunto(s)
Síndrome de Inmunodeficiencia Adquirida/complicaciones , Neoplasias Encefálicas/virología , Infecciones por Virus de Epstein-Barr/virología , Pericitos/patología , Neoplasias Vasculares/virología , Síndrome de Inmunodeficiencia Adquirida/virología , Adulto , Neoplasias Encefálicas/patología , Diagnóstico Diferencial , Endotelio Vascular/patología , Infecciones por Virus de Epstein-Barr/patología , Hemangiopericitoma/patología , Herpesvirus Humano 4 , Humanos , Inmunohistoquímica , Hibridación in Situ , Leiomioma/patología , Neoplasias Hepáticas/secundario , Masculino , Miocitos del Músculo Liso/patología , Pericitos/virología , Neoplasias Vasculares/patologíaRESUMEN
BACKGROUND: Based on the spectrum of histological features, Kaposi's sarcoma (KS) is grouped into patch, plaque and nodular stages. The histological changes overlap, especially with lesional evolution. To date, intravascular KS is undocumented. METHODS: A clinicopathological description of six cases of intravascular KS. RESULTS: Clinical: There were four men and two women (mean age = 65 years). Four patients, who presented clinically with classic (sporadic) KS, developed solitary violaceous nodules on the extremities. Two patients with acquired immune deficiency syndrome-related KS had disseminated cutaneous KS lesions in all stages of evolution. Six months to 3 years follow-up showed no evidence of systemic KS in any of the patients. Histopathology: Exclusive intravascular growth was seen in five patients. The vascular channels, highlighted by mural immunostaining with desmin and anti-smooth muscle actin, had the histological features of veins. Intravascular growth was characterized by interlacing fascicles of human herpesvirus 8, CD31 and CD34-positive spindle cells with formation of cleft-like spaces, erythrocyte extravasation, hyaline globules and a lymphoplasmacytic infiltrate. One patient had a proliferation of irregular, vascular channels in the desmin in addition to the intravenous growth. CONCLUSION: Intravascular KS is a peculiar hitherto unrecognized morphological variant of KS that does not seem to be associated with an increased risk of aggressive behaviour.
Asunto(s)
Sarcoma de Kaposi/patología , Neoplasias Cutáneas/patología , Neoplasias Vasculares/patología , Anciano , Anciano de 80 o más Años , Femenino , Herpesvirus Humano 8 , Humanos , Masculino , Persona de Mediana Edad , Sarcoma de Kaposi/metabolismo , Sarcoma de Kaposi/virología , Piel/irrigación sanguínea , Piel/patología , Piel/virología , Neoplasias Cutáneas/metabolismo , Neoplasias Cutáneas/virología , Neoplasias Vasculares/metabolismo , Neoplasias Vasculares/virología , Venas/metabolismo , Venas/patologíaRESUMEN
Cattles suffering from chronic enzootic haematuria frequently develop urinary bladder tumours of both epithelial and mesenchymal origin mainly haemangioma and its malignant counterpart. The role of the bovine papillomavirus type-2 (BPV-2) and of its major transforming oncoprotein in naturally occurring urothelial carcinogenesis has been recently clarified. E5 interacts in vivo as in vitro with the beta receptor for the platelet-derived growth factor (PDGF). However, studies regarding tumours of mesenchymal origin such as those arising from blood vessels are lacking. We show that the BPV-2 is present in 100% of the vascular tumours of the urinary bladder examined. Twenty-six out of twenty-seven tumour samples (96%) expressed E5 while 20 out of 27 (74%) tumour samples expressed E7. The two viral oncoproteins were not expressed in normal endothelial cells. Additionally, they co-localize in neoplastic endothelial cells as demonstrated by confocal immunofluorescence. PDGFbeta receptor was also shown to be expressed and co-localizes with E5 in neoplastic blood vessels. Our results demonstrate, for the first time, that the BPV-2 is present in high percentage in tumours of mesenchymal origin arising in its natural host. Furthermore, the expression of the two viral oncoproteins confirm that the virus may have a causative role in the neoplastic process.
Asunto(s)
Papillomavirus Bovino 1/genética , ADN Viral/metabolismo , Neoplasias de la Vejiga Urinaria/veterinaria , Neoplasias de la Vejiga Urinaria/virología , Neoplasias Vasculares/genética , Neoplasias Vasculares/virología , Animales , Bovinos , Enfermedades de los Bovinos , Proteínas Oncogénicas/metabolismo , Proteínas Oncogénicas Virales , Proteínas E7 de Papillomavirus , Receptor beta de Factor de Crecimiento Derivado de Plaquetas/metabolismoRESUMEN
Intravascular lymphoma (IVL) is a rare variant of non-Hodgkin lymphoma with a predilection for skin and brain. Except a few cases of T-cell lineage, most of the reported cases were large B-cell lymphomas. We encountered a case of cutaneous IVL in a 71-year-old woman presenting with multiple erythematous patches and nodules on her trunk and extremities. The intravascular large cells showed an immunophenotype of CD3epsilon(+);, CD5(-), CD20(-), CD30(-), CD56(+), and TIA-1(+). The lymphoma cells were also positive for Epstein-Barr virus by Epstein-Barr virus-encoded RNA in situ hybridization test and the T-cell receptor gene was germline. This IVL differs from nasal type NK/T-cell lymphoma only by its intravascular nature. Only 3 cases of intravascular NK-cell lymphoma have been reported before. Because this variant is extremely rare, our case is documented and compared with the 3 previously reported cases.
Asunto(s)
Herpesvirus Humano 4/aislamiento & purificación , Células Asesinas Naturales , Linfoma no Hodgkin/virología , Neoplasias Cutáneas/virología , Neoplasias Vasculares/virología , Anciano , Femenino , Herpesvirus Humano 4/genética , Humanos , Inmunofenotipificación , ARN Viral/análisisRESUMEN
Primary leiomyosarcoma of the pulmonary artery is extremely uncommon and its cause remains unclear. We document a case of pulmonary artery leiomyosarcoma expressing Epstein-Barr virus DNA sequences in an immunocompetent patient 4 years after symptomatic Epstein-Barr virus infection.
Asunto(s)
Infecciones por Virus de Epstein-Barr/complicaciones , Leiomiosarcoma/virología , Arteria Pulmonar , Neoplasias Vasculares/virología , Adulto , ADN Viral/análisis , Resultado Fatal , Femenino , Herpesvirus Humano 4/genética , Humanos , Inmunohistoquímica , Leiomiosarcoma/metabolismo , Leiomiosarcoma/cirugía , Neumonectomía , Arteria Pulmonar/cirugía , Factores de Tiempo , Neoplasias Vasculares/metabolismo , Neoplasias Vasculares/cirugíaRESUMEN
A 42-year-old female underwent hysterectomy because of a huge uterine mass. Histologically, she was diagnosed as having intravascular lymphoma co-existing with myoma uteri. Lymphoma cells were large in size and were positive for CD5, CD20, CD45, CD79a, lambda light chain, and EBV but were negative for CD3 and cyclin D1. No other organs except for the adjoining bilateral ovaries seemed to be affected by the lymphoma cells. She received the combination chemotherapy (cyclophosphamide, doxorubicin, vincristine, and prednisolone) together with rituximab and has been well without definite disease progression. So far, this is the first case of CD5+ EBV+ intravascular large B-cell lymphoma (CD5+ EBV+ IVLBL) in the uterus of a patient who was incidentally diagnosed and successfully treated.